Related Experiment Videos

Detection of two partially structured species in the folding process of the amyloidogenic protein beta

F Chiti1, P Mangione, A Andreola

  • 1Dipartimento di Scienze Biochimiche, Università di Firenze, Viale Morgagni 50, 50134 Firenze, Italy.

Insights

Beta 2-microglobulin folding involves a rapid collapse into partially structured states, followed by slower transitions to the native form. A key intermediate resembles amyloidogenic forms, suggesting its role in dialysis-related amyloidosis.

Area of Science:

  • Protein folding dynamics
  • Amyloid formation mechanisms
  • Biophysical characterization of proteins

Background:

  • Beta 2-microglobulin (A2M) aggregates in dialysis patients, forming amyloid deposits.
  • Understanding A2M folding is crucial for elucidating amyloidosis pathogenesis.

Purpose of the Study:

  • To investigate the in vitro folding pathway of beta 2-microglobulin.
  • To identify intermediates in the A2M folding process and their relation to amyloid formation.

Main Methods:

  • Guanidine hydrochloride-induced denaturation and refolding at pH 7.4.
  • Spectroscopic techniques: fluorescence, circular dichroism (CD), 8-anilino-1-naphthalenesulfonic acid (ANS) binding.
  • Kinetic analysis: stopped-flow, double jump assays, peptidyl prolyl isomerase (PPI) use.

Main Results:

  • Significant structure formation (<5 ms) observed during refolding.
  • A two-phase folding process (fast and slow phases) with distinct rate constants.
  • Identification of a partially folded intermediate (I2) structurally similar to amyloidogenic forms.
  • Evidence against cis/trans prolyl isomerization or independent folding populations determining the slow phase.

Conclusions:

  • A sequential folding mechanism involving collapse to intermediate states (I1, I2) precedes native state formation.
  • The I2 intermediate, resembling amyloidogenic species, may be populated under physiological conditions.
  • This intermediate likely plays a significant role in beta 2-microglobulin amyloidosis during long-term hemodialysis.

Related Concept Videos